Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 4/10

vs
industry
vs
history
Cash to Debt 2.29
MELA's Cash to Debt is ranked higher than
75% of the 312 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.04 vs. MELA: 2.29 )
MELA' s 10-Year Cash to Debt Range
Min: 2.29   Max: No Debt
Current: 2.29

Equity to Asset 0.61
MELA's Equity to Asset is ranked higher than
74% of the 304 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.57 vs. MELA: 0.61 )
MELA' s 10-Year Equity to Asset Range
Min: -1.09   Max: 0.81
Current: 0.61

-1.09
0.81
F-Score: 4
Z-Score: -12.91
M-Score: 1.89
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 4/10

vs
industry
vs
history
Operating margin (%) -1816.61
MELA's Operating margin (%) is ranked lower than
56% of the 309 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9.43 vs. MELA: -1816.61 )
MELA' s 10-Year Operating margin (%) Range
Min: -8174.46   Max: -869.05
Current: -1816.61

-8174.46
-869.05
Net-margin (%) -1546.01
MELA's Net-margin (%) is ranked lower than
57% of the 309 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.28 vs. MELA: -1546.01 )
MELA' s 10-Year Net-margin (%) Range
Min: -8155.76   Max: -1085.71
Current: -1546.01

-8155.76
-1085.71
ROE (%) -143.49
MELA's ROE (%) is ranked lower than
54% of the 298 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 8.60 vs. MELA: -143.49 )
MELA' s 10-Year ROE (%) Range
Min: -233.02   Max: -53.54
Current: -143.49

-233.02
-53.54
ROA (%) -80.05
MELA's ROA (%) is ranked lower than
55% of the 313 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.93 vs. MELA: -80.05 )
MELA' s 10-Year ROA (%) Range
Min: -502.58   Max: -50.87
Current: -80.05

-502.58
-50.87
ROC (Joel Greenblatt) (%) -389.37
MELA's ROC (Joel Greenblatt) (%) is ranked lower than
52% of the 311 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 19.59 vs. MELA: -389.37 )
MELA' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -4892.42   Max: -344.46
Current: -389.37

-4892.42
-344.46
EBITDA Growth (3Y)(%) -37.80
MELA's EBITDA Growth (3Y)(%) is ranked higher than
51% of the 235 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.00 vs. MELA: -37.80 )
MELA' s 10-Year EBITDA Growth (3Y)(%) Range
Min: 0   Max: -1
Current: -37.8

EPS Growth (3Y)(%) -27.70
MELA's EPS Growth (3Y)(%) is ranked higher than
54% of the 229 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 8.10 vs. MELA: -27.70 )
MELA' s 10-Year EPS Growth (3Y)(%) Range
Min: -28.9   Max: 34.6
Current: -27.7

-28.9
34.6
» MELA's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

MELA Guru Trades in

MELA Guru Trades in

MELA Guru Trades in

Q4 2014

MELA Guru Trades in Q4 2014

Jim Simons 32,064 sh (New)
» More
» Details

Insider Trades

Latest Guru Trades with MELA

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
Forward P/E 1.15
MELA's Forward P/E is ranked higher than
100% of the 339 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 61.73 vs. MELA: 1.15 )
N/A
P/B 0.71
MELA's P/B is ranked higher than
97% of the 339 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.08 vs. MELA: 0.71 )
MELA' s 10-Year P/B Range
Min: 0.55   Max: 6.36
Current: 0.71

0.55
6.36
P/S 8.33
MELA's P/S is ranked lower than
70% of the 339 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.32 vs. MELA: 8.33 )
MELA' s 10-Year P/S Range
Min: 8.06   Max: 1330
Current: 8.33

8.06
1330
EV-to-EBIT -0.26
MELA's EV-to-EBIT is ranked higher than
52% of the 339 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 36.87 vs. MELA: -0.26 )
MELA' s 10-Year EV-to-EBIT Range
Min: -4.7   Max: 0.1
Current: -0.26

-4.7
0.1
Current Ratio 6.40
MELA's Current Ratio is ranked higher than
94% of the 309 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.62 vs. MELA: 6.40 )
MELA' s 10-Year Current Ratio Range
Min: 1.83   Max: 20.6
Current: 6.4

1.83
20.6
Quick Ratio 4.44
MELA's Quick Ratio is ranked higher than
91% of the 309 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.77 vs. MELA: 4.44 )
MELA' s 10-Year Quick Ratio Range
Min: 0.84   Max: 20.6
Current: 4.44

0.84
20.6
Days Inventory 382.53
MELA's Days Inventory is ranked higher than
52% of the 339 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 133.28 vs. MELA: 382.53 )
MELA' s 10-Year Days Inventory Range
Min: 60.42   Max: 403.31
Current: 382.53

60.42
403.31
Days Sales Outstanding 87.76
MELA's Days Sales Outstanding is ranked higher than
65% of the 339 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 69.74 vs. MELA: 87.76 )
MELA' s 10-Year Days Sales Outstanding Range
Min: 38.82   Max: 236.33
Current: 87.76

38.82
236.33

Valuation & Return

vs
industry
vs
history
Price/Net Cash 2.09
MELA's Price/Net Cash is ranked higher than
99% of the 339 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.00 vs. MELA: 2.09 )
MELA' s 10-Year Price/Net Cash Range
Min: 1.74   Max: 12.61
Current: 2.09

1.74
12.61
Price/Net Current Asset Value 0.80
MELA's Price/Net Current Asset Value is ranked higher than
100% of the 339 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.00 vs. MELA: 0.80 )
MELA' s 10-Year Price/Net Current Asset Value Range
Min: 0.67   Max: 9.04
Current: 0.8

0.67
9.04
Price/Tangible Book 0.71
MELA's Price/Tangible Book is ranked higher than
98% of the 339 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9.30 vs. MELA: 0.71 )
MELA' s 10-Year Price/Tangible Book Range
Min: 0.59   Max: 18.29
Current: 0.71

0.59
18.29
Price/Median PS Value 0.17
MELA's Price/Median PS Value is ranked higher than
99% of the 339 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.40 vs. MELA: 0.17 )
MELA' s 10-Year Price/Median PS Value Range
Min: 0.14   Max: 3.63
Current: 0.17

0.14
3.63
Earnings Yield (Greenblatt) -384.60
MELA's Earnings Yield (Greenblatt) is ranked lower than
64% of the 304 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.20 vs. MELA: -384.60 )
MELA' s 10-Year Earnings Yield (Greenblatt) Range
Min: -374.4   Max: 39368.8
Current: -384.6

-374.4
39368.8

Business Description

Industry: Medical Instruments & Equipment » Medical Instruments & Supplies
Compare:WST, BAX, COV, TMO, COO » details
Traded in other countries:E2ON.Germany,
Mela Sciences Inc was incorporated in the State of New York in December 1989 under the name Electro-Optical Sciences, Inc. and subsequently reincorporated under the laws of the State of Delaware in 1997. In April 2010, it changed its name to MELA Sciences, Inc. The Company is a medical device company focused on the commercialization of its flagship product, MelaFind, the further design and development of MelaFind and its technology. MelaFind is a non-invasive, point-of-care instrument to aid in the detection of melanoma. The MelaFind system produces a report at the point-of-care to assist in the diagnostic process. MelaFind employs light of multiple wavelengths to obtain data from clinically atypical lesions; and then the data are analyzed against its proprietary database of melanomas and benign lesions using its sophisticated algorithms. The Company competes with other imaging modalities, including molecular imaging in which tagged antibodies search for cancer cell antigens, and with molecular and genetic screening tests. The sale and marketing of MelaFind is subject to a complex system of federal and state laws and regulations intended to deter, detect, and respond to fraud and abuse in the healthcare system.
» More Articles for MELA

Headlines

Articles On GuruFocus.com
own Mar 20 2013 
The Barclays Triggers More Insider Buying Mar 13 2013 
ElectroOptical Sciences Inc Reports Operating Results (10-K) Mar 03 2011 
ElectroOptical Sciences Inc Reports Operating Results (10-Q) Nov 05 2010 
ElectroOptical Sciences Inc (MELA) CFO Richard I Steinhart buys 1,000 Shares Aug 12 2010 
ElectroOptical Sciences Inc (MELA) CEO Joseph V Gulfo buys 5,000 Shares Aug 12 2010 
ElectroOptical Sciences Inc (MELA) CEO Joseph V Gulfo buys 5,000 Shares Aug 12 2010 
ElectroOptical Sciences Inc Reports Operating Results (10-Q) Aug 06 2010 
ElectroOptical Sciences Inc Reports Operating Results (10-Q) May 10 2010 
ElectroOptical Sciences Inc Reports Operating Results (10-Q) Nov 09 2009 

More From Other Websites
4 Stocks Under $10 Making Big Moves Higher Apr 21 2015
MELA SCIENCES, INC. /NY Financials Apr 02 2015
MELA Sciences Reports 2014 Financial Results and Provides a Business Update Mar 30 2015
MELA Sciences Reports 2014 Financial Results and Provides a Business Update Mar 30 2015
MELA SCIENCES, INC. /NY Files SEC form 10-K, Annual Report Mar 30 2015
MELA SCIENCES, INC. /NY Files SEC form 8-K, Other Events Mar 10 2015
MELA Sciences Names Michael R. Stewart Its Next President and CEO Nov 28 2014
MELA Sciences To Report Third Quarter 2014 Financial Results on Wednesday, November 12 Nov 28 2014
MELA SCIENCES, INC. /NY Files SEC form 8-K, Change in Directors or Principal Officers Nov 19 2014
MELA SCIENCES, INC. /NY Files SEC form 10-Q, Quarterly Report Nov 14 2014
Outcomes Study Reports Use of MelaFind Reduced Benign Biopsies by 61% in Patients at Risk for... Oct 22 2014
UPDATE: H.C. Wainwright & Co. Initiates Coverage On MELA Sciences On Commercialization Strategy... Aug 18 2014
MELA SCIENCES, INC. /NY Files SEC form 10-Q, Quarterly Report Aug 14 2014
MELA SCIENCES, INC. /NY Files SEC form 8-K, Financial Statements and Exhibits Aug 06 2014
MELA SCIENCES, INC. /NY Files SEC form 8-K, Other Events, Financial Statements and Exhibits Jul 29 2014
MELA SCIENCES, INC. /NY Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of... Jul 23 2014
MELA SCIENCES, INC. /NY Files SEC form 8-K, Material Modification to Rights of Security Holders,... Jul 10 2014
MELA Sciences initiates study on clinical impact of MelaFind on melanoma biopsy Jun 03 2014
MELA SCIENCES, INC. /NY Files SEC form 8-K, Submission of Matters to a Vote of Security Holders May 16 2014
MELA SCIENCES, INC. /NY Files SEC form 10-Q, Quarterly Report May 14 2014

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK